OVIT — OncoVista Innovative Therapies Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $1.54m
Annual income statement for OncoVista Innovative Therapies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2010 December 31st | 2011 December 31st | 2012 December 31st | 2013 December 31st | 2014 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 1.88 | 2.2 | 1.87 | 1.52 | 2.55 |
| Operating Profit | -1.88 | -2.2 | -1.87 | -1.52 | -2.55 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.29 | -2.23 | -1.63 | -1.45 | -2.54 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.29 | -2.23 | -1.63 | -1.45 | -2.54 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 10.1 | -2.03 | -1.63 | -1.45 | -2.54 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | 10.1 | -2.03 | -1.63 | -1.45 | -2.54 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.137 | -0.105 | -0.081 | -0.067 | -0.118 |
| Dividends per Share |